Amundi

Position in LNTH — Lantheus Holdings, Inc.

CIK 1330387 Paris, I0

Position in LNTH

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$5,950,886

+$727,046 QoQ

Shares Held

78,456

-0.0% QoQ

Ownership

0.121%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Amundi holds $607,665,967 across 23 Drug Manufacturers - Specialty & Generic names. LNTH ranks #6 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	3,166,361	$374,295,531
2	UTHR	UNITED THERAPEUTICS Corp	147,599	$87,523,254
3	TEVA	Teva Pharmaceutical Industries Ltd	1,765,686	$53,182,461
4	VTRS	Viatris Inc	3,407,023	$46,028,880
5	NBIX	Neurocrine Biosciences Inc	203,637	$26,827,137
6	LNTH	Lantheus Holdings, Inc. This page	78,456	$5,950,886
7	HCM	HUTCHMED (China) Ltd	232,246	$3,474,399
8	ELAN	Elanco Animal Health Inc	98,313	$2,352,630

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,950,886	78,456	-0.0%	Shares	Defined	2026-05-18
2025-12-31	$5,223,840	78,495	+37.8%	Shares	Defined	2026-02-17
2025-09-30	$2,920,657	56,944	-68.2%	Shares	Defined	2025-11-14
2025-06-30	$14,650,073	178,965	-3.2%	Shares	Defined	2025-08-13
2025-03-31	$18,035,503	184,790	+4.4%	Shares	Defined	2025-05-15
2024-12-31	$15,830,124	176,952	+529.5%	Shares	Defined	2025-02-07
2024-09-30	$3,085,072	28,110	-2.1%	Shares	Defined	2024-11-13
2024-06-30	$2,304,403	28,701	-2.3%	Shares	Defined	2024-08-14
2024-03-31	$1,827,926	29,369	—	Shares	Defined	2024-05-15
No filing history on record for this holder in this stock.